ARTICLE | Financial News

Angion withdraws IPO

October 25, 2014 12:56 AM UTC

Angion Biomedica Corp. (Uniondale, N.Y.) withdrew its proposed IPO on NASDAQ, citing market conditions. In June, the company amended its IPO to sell 2.7 million shares at $10-$12. At $11, the company would have raised $30 million and been valued at $73.1 million. In April, Angion filed to raise up to $34.5 million. Aegis Capital was the sole underwriter. ...